← All Products
Healing & Recovery

TB-500

A synthetic fragment of Thymosin Beta-4 researched for its systemic anti-inflammatory and tissue repair properties across muscle, tendon, and connective tissue.

◆ Evidence Level: Primarily Animal ResearchThymosin beta-4 (TB-500) has been studied primarily in animal models for wound healing and tissue repair. Human clinical data is very limited. See references →
Class
TB4 Fragment
Route
SubQ / IM
Half-Life
~14 Days
Frequency
2x Weekly

Last updated: October 2026 · Editorial Policy

What Is TB-500?

TB-500 is a synthetic version of the naturally occurring 43-amino-acid peptide Thymosin Beta-4 (Tβ4). It is one of the most abundant intracellular proteins in the human body, found in nearly every tissue and cell type. TB-500 specifically replicates the active region of Tβ4 responsible for actin binding, cell migration, and anti-inflammatory signaling.

Unlike localized healing peptides such as BPC-157, TB-500 exerts systemic effects throughout the body. It upregulates actin, a cell-building protein critical for tissue repair, and promotes the migration of endothelial and keratinocyte cells to sites of injury. This makes it a subject of research interest for injuries involving muscle, tendon, ligament, and connective tissue.

Head to Head

BPC-157 vs TB-500

Read Comparison →

Mechanism of Action

TB-500’s primary mechanism centers on its interaction with actin, G-actin in particular. By sequestering G-actin monomers, it promotes cell motility and migration–two processes essential for wound repair and tissue regeneration.

Key Pathways

Research Applications

Musculoskeletal Repair

TB-500 is most widely studied for muscle strains, tendon injuries, and ligament damage. Its systemic distribution means it reaches injury sites throughout the body without requiring localized injection, making it a practical option for multi-site or hard-to-reach injuries.

Cardiac Tissue

Animal studies have shown Tβ4 promotes cardiac repair following ischemic injury, activating epicardial progenitor cells and reducing scar formation in heart tissue. This remains an active area of preclinical research.

Dermal Wound Healing

TB-500 accelerates dermal wound closure in research models by promoting keratinocyte migration and organized collagen deposition, resulting in faster healing with reduced scarring.

Neuroprotection

Emerging research suggests Tβ4 may support neuronal survival and reduce inflammation following central nervous system injury, though human data remains limited.

Dosing Protocol

TB-500’s extended half-life (~14 days) allows for less frequent dosing compared to most peptides. A common approach involves a loading phase followed by a maintenance phase.

ProtocolDoseFrequencyNotes
Loading Phase2–2.5 mg2x weeklyRun for 4–6 weeks to saturate tissue
Maintenance2 mg1x weeklyContinue 4–8 weeks after loading
Acute Injury2.5 mg2x weeklyHigher frequency for active recovery

Buy TB-500

Third-party tested. Certificate of analysis available. For research use only.

2 mg Vial
Purity: 99.2%
$19.99

Preparation & Storage

Reconstitution

Supplies: peptide vial, bacteriostatic water, insulin syringes (29–31 gauge), alcohol swabs.

  1. Clean both vial tops with alcohol swabs and let dry
  2. Draw 2 mL of bacteriostatic water into the syringe
  3. Insert needle into peptide vial at an angle against the glass wall
  4. Let water run slowly down the side – never squirt directly onto powder
  5. Gently swirl until fully dissolved – never shake
  6. Solution should be clear – discard if cloudy or contains particles

Concentration: 5 mg in 2 mL = 2,500 mcg/mL

Storage

Cycling

Typical research cycle: 4–8 weeks. Results generally reported within 2–3 weeks.

<